Clinical Trials Logo

Filter by:
NCT ID: NCT02596126 Completed - Clinical trials for Myocardial Infarction

Secondary Prevention of Cardiovascular Disease in the Elderly Trial

SECURE
Start date: July 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a polypill strategy containing aspirin (100 mg), ramipril (2.5, 5 or 10 mgs), and atorvastatin (40 mgs) compared with the standard of care (usual care according to the local clinical practices at each participating country) in secondary prevention of major cardiovascular events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in elderly patients with a recent myocardial infarction.

NCT ID: NCT02595983 Completed - ATTR Amyloidosis Clinical Trials

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Start date: October 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the safety and effectiveness of revusiran (ALN-TTRSC) in adults with transthyretin-mediated amyloidosis (ATTR), whose disease has continued to worsen after liver transplantation. Dosing has been discontinued; patients are being followed-up for safety.

NCT ID: NCT02595970 Completed - Psoriasis Clinical Trials

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

IPSI-PSO
Start date: May 20, 2015
Phase: Phase 3
Study type: Interventional

Evaluate psoriasis severity and its psychosocial impact using a novel Patient Reported Outcome (the Simplified Psoriasis Index SPI) at 16 weeks, as well as long-term safety, tolerability and efficacy of secukinumab administered subcutaneously during 52 weeks (plus extension) in patients with moderate to severe psoriasis.

NCT ID: NCT02595853 Completed - Clinical trials for Gastrointestinal Bleeding

Efficacy of a Novel Hemostatic Powder in GI Bleeding

GRAPHE
Start date: October 2014
Phase:
Study type: Observational

Hemospray™ is a new endoscopic hemostatic powder. Aims of this multicenter prospective study is to determine effectiveness of Hemospray™ on short and medium term in different clinical situations, predictive factors of rebleeding after Hemospray™ application, and feasibility of the application of hemostatic powder in routine clinical practice studying in a large sample of patients.

NCT ID: NCT02595476 Completed - Pain Clinical Trials

Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus

Start date: January 2015
Phase: N/A
Study type: Interventional

A standardized tetanic stimulation is applied to patients under propofol-remifentanil TCI, in a cross-over fashion, at two different levels of anesthesia monitored by the BIS: BIS 25 and BIS 55. Remifentanil target remains constant during the whole study period (1 ng/ml). Pupillary reflex dilation is recorded after each stimulation.

NCT ID: NCT02595281 Completed - Ovarian Carcinoma Clinical Trials

HE4 as a Relapse Biomarker in Ovarian Cancers

PRONOV4IR
Start date: April 1, 2016
Phase: N/A
Study type: Interventional

HE4 is a more sensitive marker than CA-125 in patients with ovarian cancers. The interest of serum HE4 before surgery has been demonstrated to predict overall survival and its interest has also been shown in combination with CA-125 (ROMA algorithm) to identify high risk patients. To date, no study shows clearly the predictive potential of serum HE4 as an early relapse biomarker in ovarian cancers.

NCT ID: NCT02595125 Completed - Contraception Clinical Trials

Study Assessing the Reduction of Pain Felt During Installation Intra- Uterine Device by Direct Technique

DIRECTE
Start date: February 24, 2016
Phase: N/A
Study type: Interventional

Intrauterine devices (IUDs) are contraceptive methods of long-acting (from 3 to 10 years depending on the model) and among the most effective. However, there are many obstacles to the use of IUDs including pain felt by patients during installation. Several medical means were studied without evidence of their efficacy in pain related to IUD insertion. In order to remove this brake, it's important to find another way to act against this pain. The direct technique is one of the techniques described by health professionals. It seems trusted by its users as a more reliable technique but also less painful for patients. However, there is no study available on its evaluation. The aim of this study is to investigate the interest of the direct technique in reducing the pain experienced by patients during installation.

NCT ID: NCT02595112 Completed - Clinical trials for Staphylococcal Infections

Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery

SREENSTAPH2
Start date: February 4, 2016
Phase: N/A
Study type: Interventional

Staphylococcus aureus nasal carriage is a major risk factor of infection with this bacterium. Staphylococcus aureus colonization of the posterior nasal cavity is still misunderstood. This study is aimed at evaluating the relationship between Staphylococcus aureus strains colonizing the vestibulum nasi, the sphenoethmoidal recess and the nasopharynx.

NCT ID: NCT02594956 Completed - Clinical trials for Pancreaticoduodenectomy

Impact of the Absence of Nasogastric Decompression After Pancreaticoduodenectomy

IPOD
Start date: December 16, 2015
Phase: N/A
Study type: Interventional

The use of nasogastric (NG) decompression after pancreaticoduodenectomy (PD) is a current practice. NG tube is associated with a high rate of morbidity including pulmonary morbidity, delayed gastric emptying and finally an increased length of hospital stay. The absence of NG decompression could be the corner stone of the concept of the enhanced recovery program after PD.

NCT ID: NCT02594722 Completed - COPD Clinical Trials

Metabolism and Oxygen Consumption During Functional Electrical Stimulation Cycling in COPD

Start date: April 2016
Phase: Phase 3
Study type: Interventional

Chronic Obstructive Pulmonary Disease (COPD) had systemic repercussion and lead to peripheral muscular dysfunction. Muscular atrophy limits aerobic capacity and is a major limitation of daily activity and quality of life. Technologies likes' neuromuscular electrical stimulation (NMES) are currently being adapted and tested to support exercise training. The investigators hypothesized that functional electrical stimulation cycling improves VO2 and aerobic capacities during exercise compared to endurance training.